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This is a review of exposure conditions, clinical presentation, and morbidity of children and adults
with indoor fungal exposure such as toxic Stachybotrys chartarum. Indoor exposure was
characterized using different methods including microscopic, culture, cytotoxicity screening tests,
and chemical analyses. Clinical case histories and physical and laboratory findings are presented
of children (age < 18 years, n = 22; mean age 9 years; 60% females) and adults (age > 18 years,
n = 125; mean age 39 years, 67% females) who consulted an environmental health specialty clinic.
In the pediatric patients' exposure history, widespread fungal contamination of water-damaged
building materials with known toxic or allergic fungi was identified. Primarily disorders of the
respiratory system, skin, mucous membranes, and central nervous system were reported. Some
enumeration and functional laboratory abnormalities, mainly of the lymphatic blood cells, were
observed, although no statistically significant differences were found. IgE or lgG fungi-specific
antibodies, used as exposure markers, were positive in less than 25% of all tested cases. In an
evaluation of a symptomatic girl 11 years of age (sentinel case investigation) living in an apartment
with verified toxigenic fungi (i.e., S. chartarum), several health indicators showed improvement after
exposure cessation. Key words: allergy, bioaerosol, exposure, fungi, health, morbidity, mycotoxins,
Stachybotrys, toxicity. - Environ Health Perspect 107(suppl 3):489-494 (1999).
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Indoor exposure to fungi such as toxin-
producing Stachybotrys chartarum (aka
Stachybotrys atra) growing on wet building
materials is gaining recognition as an
important but challenging environmental
risk factor for a variety of illnesses with
public health implications (1,2). S. char-
tarum has been associated with serious
adverse health effects in animals and
humans and has in the past been found
primarily in agricultural environments (3).
High exposure levels of airborne patho-
genic fungi in the work environment have
been reported among farmers, woodwork-
ers, and composting waste workers but
may also be found among hospital and
office workers or occupants ofhomes with
significant water damage or with defective
ventilation systems (4-7). In recent med-
ical/epidemiologic investigations, an asso-
ciation has been described between high
exposure to S. chartarum and toxic inflam-
matory effects in infants (8-10), in office
workers handling moldy paper materials
and breathing fungal-contaminated air
(11,12), and in courthouse workers (13).
These effects are thought to be related to
toxic metabolites (mycotoxins) produced
by certain fungi such as those in the gen-
era Stachybotrys, Aspergillus versicolor,
Penicillium, Trichoderma, and Fusarium.
S. chartarum appears clinically important
because it produces biologically very potent
mycotoxins such as trichothecenes (i.e.,
satratoxins) and spirolactons that interfere
with protein synthesis on the DNA level
and the cellular or humoral immune sys-
tem in in vitro systems (14,15). The pro-
duction of mycotoxins depends on
environmental conditions and substrates
and is not evident by macroscopic growth
characteristics (16,17).
This study describes the health problems
of a group ofselected children who con-
sulted an environmental health specialty
clinic and compares those findings to those
for adults with similar fungal exposure
history. Further, the results ofa sentinel case
investigation are presented as an example of
a positive health intervention outcome
(secondary prevention).
Methods
StudyGroupSelecton andDescrption
This is a descriptive study of patients
evaluated in an ambulatory occupational
and environmental health clinic, including
self- and physician-referred patients pri-
marily from the northeastern United
States. A sample of patients less than 18
years of age was selected as a pediatric
sample because at that age completion of
major organs and lymphoid maturity are
achieved. The pediatric sample (age < 18
years, n = 22; mean age 9 years; 60%
females) and a sample ofadult patients (age
> 18 years, n = 125; mean age 39 years,
67% females) were included if they had a
verifiable history ofindoor exposure to fun-
gal air contaminants and ifthey had com-
pleted a standardized health symptom
questionnaire. Fungal exposure was consid-
ered positive if industrial hygiene survey
information and data confirmed the pres-
ence offungi and significant moisture prob-
lems (leaks, flooding, condensation, etc.).
In addition, for comparison, descriptive
data from an earlierstudyare presented that
included well-documented exposure and
that used the same core questionnaire. The
earlier study included a nonexposed adult
population with similar demographics as a
control group (11).
HealthSymptomsSurvey
The health symptoms survey had been
adapted with slight modification from the
Mount Sinai Medical Center Fungal
Health Survey Questionnaire (11).
Cumulative symptom complex scores
were computed by combining separate
questions related to particular organs:
upper respiratory system (nasal irritation,
burning, itchiness, stuffiness and conges-
tion, nasal bloody discharge, throat irrita-
tions, and soreness); lower respiratory
system (cough, shortness ofbreath, wheez-
ing, chest congestion, and tightness); cen-
tral nervous system (severe headaches,
concentration problems, irritability,
dizziness or lightheadedness, sleeping
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problems, fatigue); eyes (burning, irritation,
blurry vision); skin (burning, erythematous
rash, hair loss); constitutional (low-grade
fever, tender/swollen lymph nodes, flulike
symptoms), and history of previously
diagnosed allergy.
LaboratoryTesting
Laboratory tests were performed to study
red and white blood cells, multichemistry,
and immunological parameters. The
medical laboratory tests were analyzed by
licensed commercial labs following stan-
dard quality assurance procedures (IBT
Laboratory, Kansas, MO; Specialty
Laboratory, Inc., Santa Monica, CA). To
evaluate possible type I allergic reactivity,
allergen-specific IgE was tested in a panel
for Cheatomiumglobosum;Aspergillusfimi-
gatus; Cladosporium; Penicillium notatum;
S. atra; mouse, rat, and pigeon serum
proteins; and American cockroach. A panel
of IgG was measured and considered as
marker ofexposure for Micropolysporafaeni,
Thermoactinomyces spp., Alternaria alter-
nata, A.fimigatus, Aureobasidiumpullulans,
P. notatum, Phoma herbarum, Trichoderma
viride, pigeon droppings, pigeon serum,
bovine serum, Cladosporium, and S. atra.
Allergen testing material was provided
by Pharmacia & Upjohn Diagnostics
(Bridgewater, NJ).
ExposureAssessment
Indoor exposure to fungal materials was
assessed and verified by experts in the field
generally relying on test methods described
by the American Industrial Hygiene
Association field guide for the determina-
tion ofbiologic contaminants (18). Indoor
exposure was characterized using micro-
scopic, culture, and mycotoxin cytotoxicity
screening tests (MTT). Subjects with a his-
tory of indoor fungal exposure that was
deemed to be excessive or atypical com-
pared to outside or other references were
included in the analysis presented here.
Sentinel CaseExample
In addition to the epidemiologic data, a
clinical case example is presented here to
illustrate the complexity ofcomprehensive
exposure and health assessment and also to
document the benefits of a positive envi-
ronmental intervention outcome (exposure
cessation). In the case investigation, the
indoor environment and health complaints
of a low-income family living in an apart-
ment building in Spanish Harlem, New
York, were examined. The apartment had a
longstanding history of moisture problems
and widespread visible fungal growth on
interior surfaces (> 100 ft2). The mother
ofan eleven-year-old daughter had noticed
that the general health of her daughter
improved when she was away from the
New York apartment. The daughter had a
history of recurrent bouts of asthma,
pneumonia, bronchitis, sinusitis, and mid-
dle ear disease. Upon return to the apart-
ment, previous symptoms and illnesses
recurred or worsened. Observations by the
primary care providers confirmed this his-
tory. It should be noted that the daughter
(index case/subject A) had a diagnosis of
velo-cardio-facial syndrome (a variant of
DiGeorge syndrome), which is associated
with T-cell deficits due to thymic hypo-
plasia and an increased susceptibility to
infections. Although this condition is asso-
ciated with disorders similar to or identical
with the studied fungal outcomes, this case
was chosen nonetheless because the history
of symptoms given by the mother sug-
gested that environmental factors strongly
influenced the girl's health. Other family
members were also included in the case
study, as they also reported variation of
their health status dependent upon envi-
ronmental changes. A suitable case control
was not available and such a study was not
feasible at the time of this investigation.
However, the adult occupant ofthe apart-
ment that was used as a control in the envi-
ronmental assessment was asymptomatic
and free ofanyatopic diseases.
We investigated the environmental con-
ditions inside the apartment and compared
them to outside conditions and a reference
apartment inside the same building that did
not have visible evidence ofmoisture and
fungal problems (healthy adult occupant).
In addition to the index case, the brother
(subject B; 21 years ofage) and the mother
(subject C; 50 years ofage) were studied
because they reported symptoms, although
less severe. Subject A (who had lived since
birth in the apartment) and subject C spent
most ofa typical day inside, whereas subject
B was only in the apartment during the
night. The family was removed from the
contaminated apartment and retested after a
period of8 weeks (pulmonary function and
T-lymphocyte flow cytometry) and again
after 4 months (lymphocyte flow cytome-
try). There were never any pets in the apart-
ment. The apartment building had a known
historyofcockroach and rat infestation.
FunlEiposureSampng
Viable fungal air samples were collected on
cornmeal agar and malt extract agar using a
single-stage (N6) impacter (Andersen
Instruments Inc.,Atlanta, GA) operated at a
flowrate of28.3 L/min for 2 min. Total air-
borne fungal materials (including nonviable
spores) were sampled using an Arca sam-
pling pump and Air-O-Cell air sampling
cassettes (SKC, Inc., Eighty Four, PA) with
a 15 L/min flow rate for 3 min. The cas-
settes were analyzed; results were reported in
fungal structures percubic meterofair.
ToxicityScreemning
The MTT cytotoxicity screening test is
particularly sensitive to S. chartarum tox-
ins (i.e., Satratoxin). The MTT cell cul-
ture assay and a swine kidney target cell
line were used as a direct method. Bulk
samples were tested directly in the toxicity
tests for presence of mycotoxins (19,20).
The principle ofthis bioassay is based on
the transformation of the yellow tetra-
zolium salt MTT byviable, living cells (via
mitochondrial dehydrogenase) to purple -
formazans. The optical density ofthe for-
mazans can be measured by an enzyme-
linked immunosorbent assay (ELISA)
reader at a wavelength of 540 nm. Swine
kidney monolayer cells (SK), known to be
sensitive to mycotoxins, were used as target
cells. The minimum concentrations ofthe
test reagents to cause toxic effects were
determined on the basis ofthe statistically
determined values of80% cleavage activity.
CockroachAntigenSampling
Dust samples were collected using filter
media attached to a vacuum cleaner hose.
Approximately 1 m2 offloor surface was
vacuumed. The dust samples were analyzed
using an immunologic assay to identify the
presence ofa cockroach allergen (Bla g 1).
Results are reported in micrograms of
cockroach allergen per gram ofdust (,ug/g).
PesticideSampling
A 100-cm2 area offloor surface was wiped
with sterile gauze saturated with toluene.
The sample wipes and bottles were pre-
pared, and later all samples were scanned
by the Wisconsin Occupational Health
Laboratory (Madison, WI) for presence of
pesticide contamination.
Dust mite or other animal antigens
were not measured. (This was a winter
period and no household animals were pre-
sent.) Other chemical or organic com-
pounds were not measured because the
industrial hygienist did not observe any
unusual presence or use of household
chemicals. An indoor asbestos and lead
screeningwas negative.
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Results
ReviewofClinic Records
The analysis of clinically recorded health
symptoms and organ complaints of
patients with a history of indoor fungal
exposures showed a high prevalence
(> 50% ofall respondents) of symptoms of
upper and lower airways, eyes, and central
nervous system. Children also showed a
high prevalence ofsymptoms, although the
absolute percentage rate was slightly lower
than that of adults (Table 1, Figure 1).
Compared to the office workers with
health problems associated with fungal
exposure and the nonexposed controls,
children appeared to complain slightly
more about upper airway problems (symp-
toms related to rhinitis, sinusitis, laryngitis)
and slightly less about lower airway prob-
lems (symptoms related to bronchitis,
asthma, or pneumonitis). Skin, eye, and
central nervous system complaints were
present in more than 40% ofrespondents,
with similar high proportions for the
adults. Excessive physical and mental
fatigue (fatigue) was reported by about
one-third of the children interviewed and
by about halfthe adults (54%). The rate of
preexisting and diagnosed allergy in
patients was less than 20% and lower than
in the comparison groups. The higher
prevalence of symptoms among patients
and exposed office workers relative to non-
exposed controls was not likely due to
group differences in age, gender, or smok-
ing, as groups were similar on these poten-
tial confounders (except, ofcourse, for the
younger ages ofchildren).
Five percent of the children had any
evidence of specific IgE antibodies to
tested fungal allergens (except S. atra), 9%
had an IgE reaction (borderline values),
and none had an elevated IgG (> 40
mcg/mL) to S. atra. None of these chil-
dren had a specific antibody reaction to
cockroaches. Complete lymphocyte and
other immunoglobulin analysis were
Table 1. Results and comparison of symptom survey after indoorfungal exposure.a
Office workers with
Children Adults fungal exposure Controls
(< 18 years ofage) (. 18 years ofage) (adults)a (adults)a
Organ system affected n=22(%) n= 125(%) n=53(%) n= 21 (%)
Respiratory system
Upperairways 64 80 57 43
Lower airways 50 88 76 43
Skin 41 61 47 19
Eyes 50 66 57 19
Central nervous system 64 80 70 52
Constitutional 18 6 28 5
Fatigue 32 54 24 5
Previous diagnosis ofallergy 18 25 60 48
Age (years) 9.3 44.5 34.8 37.5
Female gender (%) 60 67 73.6 52.4
Smoker(%) 0 22.4 18.9 19
"Proportion ofsubjects reporting at least one symptom in each symptom complex. bData from Johanning etal.111).
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Figure 1. Health survey: children vs. adults. Forexplanation of office workers and controls, see text.
available for only five children and are not
reported here. On the basis of the review
of available industrial hygiene data, about
90% of the children had verifiable expo-
sure to higher-than-normal indoor levels
of primarily Penicillium and Aspergillus
spp., and at least 41% ofthe children had
documented exposure to S. atra.
Sentinel Case Example
Results of the clinical evaluation showed
that all three subjects had objective evi-
dence of respiratory disorders (mixed
restrictive and obstructive abnormalities)
and abnormalities ofthe T-cell flow cytom-
etry subgroups (Tables 2, 3). Subjects A
and B had very low CD4 counts, although
no histories ofHIV infection or similar risk
factor for low CD4 T-cell counts were evi-
dent except for the verified genetic defect
(velo-cardio-facial syndrome) in the index
case. The ratios ofCD4/CD8 were low and
remained low after removal (1.2-1.4) in all
subjects. SubjectA had a low positive eleva-
tion ofIgE to S. atra (873 counts) with a
borderline total IgE elevation of 138 (> 158
indicative ofatopic allergy). Subject B had
no IgE or IgG elevation. None of the
subjects was allergic to cockroach allergen.
After leaving the apartment, all subjects
reported a marked improvement and a par-
tial resolution oftheir health problems. Less
frequent and severe cough episodes, less
chest discomfort, and fewer breathing prob-
lems, headaches, fatigue, and flulike symp-
toms were noted. Pulmonary function
improved in all three subjects (Table 2) and
the lymphocyte enumeration measured 8
and 16 weeks after removal (Table 3)
appeared to show some minimal improve-
ment in some parameters. The index case
had a PWM and CON mitogen response
abnormality during the exposure period
(data not shown). The results ofthe T-lym-
phocyte function (mitogen proliferation)
tests performed 16 weeks after removal were
normal in all subjects. These results and the
lack ofclinically significant viral or bacterial
infections after removal from exposure indi-
cate only a minor remaining immunodefi-
ciency, which could be explained by the
known preexisting genetic abnormality.
Inside the apartment, approximately
70-100 m2 ofsurface area (walls, ceilings,
around the window air conditioning unit,
the doors, and window frames) were cov-
ered with a blackish-colored growth.
Airborne fungal counts (viable and nonvi-
able) were significantly higher (10-200x)
than the outside or the control apartment
used as a reference (Table 4). Predominant
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Table2. Pulmonary function test before and after exposure cessation (intervention in case example).a
Preintervention Postintervention
SubjectA(indexcase)
FVC(L/% of predicted) 1.65(65) 2.17 (76)
FEV1 (L/% of predicted) 1.60)65) 1.73 (69)
Ratio(%) 96 80
Subject B
FVC(L/% ofpredicted) 4.7(87) 4.9(90)
FEV1 (L/% of predicted) 3.3 (71) 3.8(81)
Ratio (%) 70 78
SubjectC
FVC (L/% ofpredicted) 1.98(67) 2.17 (77)
FEV1 (L/% ofpredicted) 1.7 (70) 1.9(81)
Ratio (%) 87 87
&All subjects are nonsmokers; predicted normals based on height, gender, race, weight, age. For children <18 years of age, data
fromPolgarand Promadhat(24); data foradults >18years ofage, data from Knudson et al.(25,26).
Table 3. Lymphocyte screening results(case example).
Postintervention Postintervention
Test Preintervention (8 weeks) (16weeks)
SubjectA(index case, 12years ofage)
MatureTcells CD3(%) 67 65 62
Absolute CD3(#) 601 358 450
HelperCD4(%) 26 30 31
Absolute CD4(#) 233 165 230
SuppressorCD8(%) 22 19 24
Absolute CD8(#) 197 105 180
CD4/CD8 1.2 1.6 1.3
NKcells(%) 9 16 21
NKcells(#) 81 88 150
Subject B(22years ofage)
MatureTcells CD3(%) 62 65 58
Absolute CD3(#) 558 619 672
Helper CD4(%) 34 34 28
Absolute CD4(#) 306 324 330
SuppressorCD8(%) 25 28 25
Absolute CD8(#) 225 267 294
CD4/CD8 1.4 1.2 1.1
NKcells(%) 24 21 24
NKcells(#) 216 200 276
Subject C(51 years ofage)
Mature Tcells CD3(%) 72 71 71
Absolute CD3(#) 1493 886 1110
HelperCD4(%) 38 39 43
Absolute CD4(#) 788 487 670
Suppressor CD8(%) 35 31 41
Absolute CD8(#) 726 387 640
CD4/CD8 1.2 1.3 1.1
NKcells (%) 15 10 13
NKcells(#) 311 125 200
NK, natural killer.
indoor airborne fungi were Cladosporium,
Aspergillus, Penicillium, and S. chartarum.
Bulk samples taken from the problem
apartment showed a high concentration of
S. chartarum, A. versicolor, and Cladosporium
All bulk samples taken from the home (bed-
room, bath, and kitchen) were toxic to
highlytoxic in theMIT screening test.
Cockroach allergen Bla g 1 in sampled
floor dustwas considered high, based on the
classification by the National Cooperative
Inner-City Asthma Study, although the
maximum concentration in the Inner-City
Asthma Study was 1,190 U/g dust [median
8 Ulg) (21)]. No pesticide toxins were
detected inside the apartment.
Discussion
The symptom survey ofchildren evaluated
in our specialty clinic indicates a high rate
ofmorbidity related primarily to the upper
airways, skin and mucous membranes and,
to a lesser degree, lower airways. In all
cases we confirmed that these children had
all been living in indoor environments
with high levels offungi, often species not
normally found indoors or in such concen-
trations compared to the outside air (i.e.,
S. chartarum, A. versicolor, Trichoderma).
Our results are in agreement with a number
ofprevious studies. Arecent reviewofthelit-
erature investigating the association of
wheeze and cough and damp or mold found
that the adjusted odds ratio for an increased
risk ofchildren was generally in the range of
1.5-3.5 (22). The high rate (about two-
thirds) ofcentral nervous system problems
among children from moldy homes suggests
a complex exposure-associated morbidity
reaction with a pathologic pathway that
cannot readily be explained by atopy or
allergy (IgE-mediated). The health com-
plaints summarized by organ system were
similar for children compared to adults,
although the absolute percentage rate of
complaints was slightly lower for children.
The rate ofreported symptoms was higher
than that ofa nonexposed adult control
group in almost all categories except for a
previous diagnosed history ofallergy. None
ofthe queried children had evidence ofan
allergy to cockroaches, which has been
described as an important predictor ofenvi-
ronmental-associated asthma (21). On the
basis ofour assessment ofthe clinical cases,
morbidity related in time and place to
indoor fungal exposure appears to be wide-
spread in environments with a history of
flooding, water leaks, moisture problems,
and ventilation defects that resulted in
intense fungal growth on interior building
materials or furniture.
Differences were not analyzed for
statistical significance because of method-
ological issues and limitations such as
small sample size and different time and
location of measurements. The response
variations and group differences may be
due to selection bias, biologic differences,
or survey limitations (e.g., children were
less used to questionnaire formats, were
unfamiliar with interview techniques, or
were assisted by parents).
Only 2 children and 13 adults had
positive (abnormal) laboratory findings for
the presence ofIgE- and IgG-specific fun-
gal antigens. In this small sample, neither
the presence of positive antigen findings
nor a fungal exposure history showed a sta-
tistically significant association with symp-
toms. The small number ofsubjects with
abnormal laboratory findings (only 5 chil-
dren had undergone complete lymphocyte
testing) did limit the statistical power of
analysis ofgroup differences in laboratory
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Table 4. Sentinel case exposure assessment-bulk and air sampling results.'
Quantity Comments (predominant)
Fungiculture (CFU/m3) (viable)
Inside 1993 to >7067 Clado., Asp., PNC, Stachy.
Control 194to 336 Clado, PNC
Fungal structure/mi3 (nonviable)
Inside 180,000 to 658,000 ASP/PNC like, Clado., Stachy.
Control 3656 to 4700 Clado, Basidiospores
Bulk sample (CFU/g)
Wallpaper (living room) 1.6-2 x 1,000,000 Stachy. (50-66%), A. versicolor, PNC
Toxicity tests (MTTscreening) Electron microscopyb
Wallpaper (bedrooms, samples 1-3) Toxic to highly toxic Stachy. +++, PNC+, ASP+
Kitchen (wallpaper) Highlytoxic Stachy. ++ Fusariurn+ Trichoderma+
Nonfungal tests
Cockroach allergen (Bla gl) 18 to 36 Microgram per gram dust
Pesticides 0 None detected
Abbreviations: Clado, Cladosporium; Asp, Aspergillus; PNC, Penicillium; Stachy, Stachybotrys; CFU, colony-forming units; MTT,
mycotoxin cytotoxicity screening tests. 'Varioustest protocols described in "Methods." b+to +++= lowto high quantity.
findings. The differences in laboratory test
results may be related to a variety offactors
including the differences in exposure dura-
tion, latency, timing oflaboratory testing
relative to exposure and testing, and tem-
porary medical treatment effects. A study
ofa larger number ofchildren with similar
exposure (children in kindergarten or
schools) that included testing of biologic
markers at the same time would be benefi-
cial for epidemiologic studies. Presently
there is not a reliable mycotoxin biomarker
available for clinical screening studies.
Therefore, clinicians rely on indirect labo-
ratory effects measures such as T-lympho-
cyte responses and immunoglobulins
counts. Advances in immunology, labora-
tory, and diagnostic methods may ease
clinical diagnosis in the future.
In the case example investigation, a key
factor was the reported history of vari-
ability of health complications depending
on the indoor environment, i.e., the dra-
matic health improvement away from the
fungal exposure inside the apartment. We
presented this case example because it
appears to demonstrate that such fungal
exposure can significantly aggravate and
complicate pre-existing immunological
disease. The exposure was not only affect-
ing the index case but also the brother and
mother who shared the apartment with
her but had no history of genetic abnor-
malities. Inside the apartment we identi-
fied very high levels offungi indoors, with
a predominance of Cladosporium and
toxigenic S. chartarum. The presence of
airborne S. chartarum in indoor environ-
ments is considered by experts to be highly
uncommon in normal buildings and unac-
ceptable from a public health perspective.
The MTT cytotoxicity tests showed that
all samples taken from the girl's home
environment had toxic metabolites (such
as trichothecene) in the fungal materials.
The fungal mass (spores) would have
become airborne when disturbed.
Blood lymphocyte changes effecting the
T-lymphocyte differentiation and subpop-
ulation proportion were measured as in
previous studies (11,23). Changes of the
T-lymphocyte population were demon-
strated in in vitro and in vivo studies but
remain difficult to interpret on an epidemi-
ological level because of only very small
differences and variations in observed
trends. In our case example, some lympho-
cyte parameters showed improvement after
exposure cessation, but these may be
within laboratory and normal daily varia-
tions. Only the index case had genetic evi-
dence ofa deletion of22ql 1.2, confirming
a velo-cardio-facial syndrome (DiGeorge
variant). Cockroach antigen (Bla gl) expo-
sure, although present in high concentra-
tion, did not result in measurable allergies
in any ofthe apartment occupants. On the
basis of available data and the observed
health improvement with exposure cessa-
tion, we concluded that indoor fungal
exposure was the probable contributing
cause of the health problems associated
with living in this apartment. Some other
unidentified agents or conditions may have
also contributed to the improved outcome,
although we think this is very unlikely
under the circumstances. Studies ofhealth
outcomes related to bioaerosol exposure
appear more complicated than monoagent
chemical exposure studies because several
biologic components (i.e., 0-glucans,
microbial volatile organic compounds,
endotoxins, allergen, mycotoxins) may
have independent or combined effects.
It is our clinical experience that
symptoms associated with mold exposure
tend to resolve with exposure avoidance
and symptomatic treatment. In some indi-
viduals, symptoms may last several weeks
to months after exposure control and in
some rare cases may not be reversible at all.
A highly increased sensitivity with recur-
rent fungal exposure has been noted by
some individuals. These variations in the
postexposure periods may be related to
differences in the exposure duration, inten-
sity, and particular conditions (different
fungal species), the biologic differences of
the immune reaction ofexposed individ-
uals, and the type ofmedical intervention
or treatment.
Children with preexisting, significant
immunological weaknesses and defects are
at increased risk and should be protected
from unnecessary fungal exposure. Long-
term benefits of such intervention (sec-
ondary prevention) and related health
indicators should be studied mnore system-
atically. Fungal exposure in indoor envi-
ronments should be included in future
environmental respiratory and-immuno-
logic disease studies, in addition to already
known indoor pollutants. It is necessary for
the physician examining a child with com-
plex respiratory problems, allergy, nervous
system disorders, and perhaps other organ
system problems, to inquire about prob-
lems in the home such as chronic water
leaks, extensive interior condensation,
flooding, and especially visible fungal
growth on interior building materials. In
many cases, effective fungal exposure con-
trol and avoidance may be all that is needed
to achieve a significant improvement in the
child's health.
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